Skip to main content
Erschienen in: Urolithiasis 6/2011

01.12.2011 | Original Paper

Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis

verfasst von: Hasan Aydin, Faruk Yencilek, Ismet Bilger Erihan, Binnur Okan, Kemal Sarica

Erschienen in: Urolithiasis | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Both the prevalence of cardiovascular risk factors and event rate are increased in patients with urolithiasis. Screening is recommended to all patients who have high cardiovascular risk. The aim of this study was to document 10-year risk of cardiovascular disease and mortality in asymptomatic patients with urolithiasis. Consecutive 200 patients with calcium oxalate urolithiasis were compared with 200 age- and sex-matched healthy controls. Ten-year cardiovascular disease risk was calculated with the Framingham Risk Score and mortality risk with SCORE risk score. Calcium, oxalate, and citrate excretion were studied as urinary stone risk factors. The results indicate that patients with urolithiasis had higher total cholesterol (p < 0.0001), lower HDL-cholesterol (p < 0.0001), and higher systolic blood pressure (p < 0.0001) and hsCRP (p < 0.0001) compared with controls. Patients with urolithiasis had a higher Framingham Risk Scores [OR 8.36 (95% CI 3.81–18.65), p = 0.0001] and SCORE risk score [OR 3.02 (95% CI 1.30–7.02), p = 0.0006] compared with controls. The Framingham and SCORE risk score were significantly correlated with urinary calcium (p = 0.0001, r = 0.460, and p = 0.005, r = 0.223, respectively) and oxalate excretion (p = 0.0001, r = 0.516, p = 0.001, r = 0.290, respectively). In multiple linear regression analysis, urinary calcium and oxalate excretion, age, sex, total cholesterol, HDL-cholesterol, hsCRP and smoking were the independent predictors of 10-year cardiovascular disease risk and urinary calcium and oxalate excretion, age, sex, total cholesterol, fasting blood glucose for 10-year cardiovascular mortality. In conclusion, patients with calcium oxalate urolithiasis carry high risk of cardiovascular disease and mortality. All patients should be screened at the initial diagnosis of urolithiasis for the risk factors.
Literatur
1.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef
2.
Zurück zum Zitat Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2009) Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3):e21–e181PubMedCrossRef Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2009) Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3):e21–e181PubMedCrossRef
3.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef
4.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235PubMedCrossRef
5.
Zurück zum Zitat Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6(4):S485–S486PubMed Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6(4):S485–S486PubMed
6.
Zurück zum Zitat Traxer O, Safar H, Daudon M, Haymann JP (2006) Metabolic syndrome, obesity and urolithiasis. Prog Urol 16(4):418–420PubMed Traxer O, Safar H, Daudon M, Haymann JP (2006) Metabolic syndrome, obesity and urolithiasis. Prog Urol 16(4):418–420PubMed
7.
Zurück zum Zitat Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21(10):1641–1644PubMedCrossRef Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21(10):1641–1644PubMedCrossRef
8.
Zurück zum Zitat WritingCommittee Members, Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122(25):e584–e636PubMedCrossRef WritingCommittee Members, Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122(25):e584–e636PubMedCrossRef
9.
Zurück zum Zitat Kappagoda CT, Amsterdam EA (2009) Assessment of risk for developing coronary heart disease in asymptomatic individuals. J Cardiopulm Rehabil Prev 29(4):207–219PubMed Kappagoda CT, Amsterdam EA (2009) Assessment of risk for developing coronary heart disease in asymptomatic individuals. J Cardiopulm Rehabil Prev 29(4):207–219PubMed
10.
Zurück zum Zitat Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003PubMedCrossRef Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003PubMedCrossRef
11.
Zurück zum Zitat Raynal G, Achkar K, El Samad R, Kikassa JC, Jorest R (2008) Cardiovascular risk associated with urolithiasis. Prog Urol 18(5):288–291PubMedCrossRef Raynal G, Achkar K, El Samad R, Kikassa JC, Jorest R (2008) Cardiovascular risk associated with urolithiasis. Prog Urol 18(5):288–291PubMedCrossRef
12.
Zurück zum Zitat Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26(3):864–868 Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26(3):864–868
13.
Zurück zum Zitat Zimmerer T, Weiss C, Hammes HP, Braun C, Hesse A, Alken P, Knoll T (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82(3):350–355PubMedCrossRef Zimmerer T, Weiss C, Hammes HP, Braun C, Hesse A, Alken P, Knoll T (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82(3):350–355PubMedCrossRef
14.
Zurück zum Zitat Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21(3):257–264PubMedCrossRef Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21(3):257–264PubMedCrossRef
15.
Zurück zum Zitat West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51(5):741–747PubMedCrossRef West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51(5):741–747PubMedCrossRef
16.
Zurück zum Zitat Mossetti G, Rendina D, De Filippo G, Benvenuto D, Vivona CL, Zampa G, Ferraro P, Strazzullo P (2008) Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Mineral Bone Metab 5(2):114–117 Mossetti G, Rendina D, De Filippo G, Benvenuto D, Vivona CL, Zampa G, Ferraro P, Strazzullo P (2008) Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Mineral Bone Metab 5(2):114–117
17.
Zurück zum Zitat Daudon M, Doré JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247PubMedCrossRef Daudon M, Doré JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247PubMedCrossRef
18.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359PubMedCrossRef Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359PubMedCrossRef
19.
Zurück zum Zitat Ford ES (2004) Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33(2):333–350PubMedCrossRef Ford ES (2004) Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33(2):333–350PubMedCrossRef
20.
Zurück zum Zitat Costa EC, de Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD (2010) Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 54(7):630–635PubMedCrossRef Costa EC, de Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD (2010) Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 54(7):630–635PubMedCrossRef
21.
Zurück zum Zitat Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350PubMedCrossRef Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350PubMedCrossRef
22.
Zurück zum Zitat Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199(6):481–485PubMedCrossRef Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199(6):481–485PubMedCrossRef
24.
Zurück zum Zitat Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21(6):426–431PubMedCrossRef Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21(6):426–431PubMedCrossRef
25.
Zurück zum Zitat Cupisti A, Meola M, D’Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G (2007) Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 61(1):86–90PubMedCrossRef Cupisti A, Meola M, D’Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G (2007) Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 61(1):86–90PubMedCrossRef
26.
Zurück zum Zitat Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology 75(6):1289–1293PubMedCrossRef Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology 75(6):1289–1293PubMedCrossRef
27.
Zurück zum Zitat Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, Juan YS (2010) Difference in urinary stone components between obese and non-obese patients. Urol Res (Epub ahead of print) Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, Juan YS (2010) Difference in urinary stone components between obese and non-obese patients. Urol Res (Epub ahead of print)
28.
Zurück zum Zitat Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun M (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219PubMedCrossRef Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun M (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219PubMedCrossRef
Metadaten
Titel
Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis
verfasst von
Hasan Aydin
Faruk Yencilek
Ismet Bilger Erihan
Binnur Okan
Kemal Sarica
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 6/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0383-9

Weitere Artikel der Ausgabe 6/2011

Urolithiasis 6/2011 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.